Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 142 No. 4142 (2012)

Acute respiratory health effects of urban air pollutants in adults with different patterns of underlying respiratory disease

  • Amar J Mehta
  • Christian Schindler
  • Laura Perez
  • Nicole Probst-Hensch
  • Joel Schwartz
  • Otto Brändl
  • Werner Karrer
  • Jean Marie Tschopp
  • Thierry Rochat
  • Nino Künzli
DOI
https://doi.org/10.4414/smw.2012.13681
Cite this as:
Swiss Med Wkly. 2012;142:w13681
Published
07.10.2012

Summary

OBJECTIVE: Whether underlying chronic respiratory diseases are susceptible factors for symptomatic episodes, which lead to primary-level care, in association with air pollutant exposures is unknown. We evaluated and compared association lag structures between daily ambient levels of nitrogen dioxide (NO2) and total suspended particulates (TSP) and respiratory symptom-related doctor visits in adults with different patterns of underlying chronic respiratory disease.

METHODS: In a time-stratified case-crossover analysis nested within a diary panel study, 459 Swiss adult participants with asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD) and healthy participants recorded occurrence of respiratory-symptom related doctor visits (n = 1,048) in one to six four-week intervals over two years. For each disease subgroup, odds ratios (ORs) for doctor visit were estimated as a function of NO2 or TSP concentrations (per 10 micrograms per cubic meter [µg/m3]) lagged between 0–13 days in a polynomial distributed lag model.

RESULTS: Higher ORs for NO2 in participants with COPD (OR: 1.17, 95%CI: 1.02–1.35) and asthma (OR: 1.15, 95%CI: 1.02–1.30) occurred at exposure lags of two and five days, respectively. Doctor visits increased by 9.1% (95%CI: 3.2–15.4%) and 4.2% (95%CI: 1.2–7.2%) over the first week following a 10 µg/m3 increase in NO2 concentration in the COPD and chronic bronchitis subgroups, respectively. The percent increase in the COPD subgroup was significantly greater (p <0.05) when compared with the healthy subgroup. Observed findings were similar for TSP.

CONCLUSIONS: Respiratory problems leading to a doctor visit, associated with an increase in exposure to NO2 and TSP, may have a faster dynamic in individuals with COPD.

References

  1. Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, Samet JM. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA. 2006;295:1127–34.
  2. Koenig JQ, Air pollution and asthma. J Allergy Clin Immunol. 1999;104:717–22.
  3. Sunyer J, Schwartz J, Tobías A, Macfarlane D, Garcia J, Antó JM, Patients with chronic obstructive pulmonary disease are at increased risk of death associated with urban particle air pollution: a case-crossover analysis. Am J Epidemiol. 2000;151:50–6.
  4. Perez L, Rapp R, Künzli N. The Year of the Lung: outdoor air pollution and lung health. Swiss Med Wkly. 2010;140:w13129.
  5. Chardon B, Lefranc A, Granados D, Grémy I. Air pollution and doctors’ house calls for respiratory diseases in the Greater Paris area (2000-3). Occup Environ Med. 2007;64:320–4.
  6. Hajat S, Haines A, Goubet SA, Anderson H. Association of air pollution with daily GP consultations for asthma and other lower respiratory conditions in London. Thorax. 1999;54:597–605.
  7. Hwang JS, Chan CC. Effects of air pollution on daily clinic visits for lower respiratory tract illness. Am J Epidemiol. 2002;155:1–10.
  8. Wong TW, Tam W, Tak Sun Yu I, Wun YT, Wong AH, Wong CM. Association between air pollution and general practitioner visits for respiratory diseases in Hong Kong. Thorax. 2006;61:585–91.
  9. Martin BW, Ackermann-Liebrich U, Leuenberger P, Künzli N, Stutz EZ, Keller R, et al. SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz Praventivmed. 1997;42:67–84.
  10. Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, Schindler C, Felber Dietrich D, Stutz EZ, et al. Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991–2003: methods and characterization of participants. Soz Praventivmed. 2005;50:245–63.
  11. Kaiser R, Schindler C, Künzli N, Ackermann-Liebrich U, Heeb D, Medici TC, et al. Use of transition probabilities to estimate the effect of smoking on the duration of episodes of respiratory symptoms in diary data: the Swiss Study on Air Pollution and Lung Diseases in Adults (SAPALDIA). Am J Epidemiol. 1998;148:600–8.
  12. Künzli N, Stutz EZ, Perruchoud AP, Brändli O, Tschopp JM, Bolognini G, et al. Peak flow variability in the SAPALDIA study and its validity in screening for asthma-related conditions. Am J Respir Crit Care Med. 1999;160:427–34.
  13. Lumley T, Levy D. Bias in the case-crossover design: implications for studies of air pollution. Environmetrics. 2000;11:689–704.
  14. Monn C, Brändli O, Schindler C, Ackermann-Liebrich U, Leuenberger P. Personal exposure to nitrogen dioxide in Switzerland. Sci Total Environ. 1998;215:243–51.
  15. Monn C, Braendli O, Schaeppi G, Schindler C, Ackermann-Liebrich U, Leuenberger P. Particulate matter <10 μm (PM10) and total suspended particulates (TSP) in urban, rural and alpine air in Switzerland. Atmos Environ. 1995;29:2565–73.
  16. Hueglin C, Buchmann B, Weber RO. Long-term observation of real-world road traffic emission factors on a motorway in Switzerland. Atmos Environ. 2006;40:3696–709.
  17. Pope CA 3rd, Schwartz J. Time series for the analysis of pulmonary health data. Am J Respir Crit Care Med. 1996;154:S229–33.
  18. Schwartz J. The distributed lag between air pollution and daily deaths. Epidemiol. 2000;11:320–6.
  19. Zanobetti A, Schwartz J, Samoli E, Gryparis A, Touloumi G, Peacock J, et al. The temporal pattern of respiratory and heart disease mortality in response to air pollution. Environ Health Perspect. 2003;111:1188–93.
  20. Peel JL, Tolbert PE, Klein M, Metzger KB, Flanders WD, Todd K, et al. Ambient air pollution and respiratory emergency department visits. Epidemiology. 2005;16:164–74.
  21. Mar TF, Larson TV, Stier RA, Claiborn C, Koenig JQ. An analysis of the association between respiratory symptoms in subjects with asthma and daily air pollution in Spokane, Washington. Inhal Toxicol. 2004;16:809–15.
  22. Sint T, Donohue JF, Ghio AJ. Ambient air pollution particles and the acute exacerbation of chronic obstructive pulmonary disease. Inhal Toxicol. 2008;20:25–9.
  23. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123:1684–92.
  24. Probst-Hensch N, Tanner M, Kessler C, Burri C, Künzli N. Prevention – a cost-effective way to fight the non-communicable disease epidemic: an academic perspective of the United Nations High-level NCD Meeting. Swiss Med Wkly. 2011;141:w13266.
  25. Probst-Hensch NM. Chronic age-related diseases share risk factors: do they share pathophysiological mechanisms and why does that matter? Swiss Med Wkly. 2010;140:w13072.
  26. Carracedo-Martínez E, Taracido M, Tobias A, Saez M, Figueiras A. Case-crossover analysis of air pollution health effects: a systematic review of methodology and application. Environ Health Perspect. 2010;118:1173–82.
  27. Janes H, Sheppard L, Lumley T. Case-crossover analyses of air pollution exposure data: referent selection strategies and their implications for bias. Epidemiol. 2005;16:717–26.
  28. Fischer A, Gehrig R, Hofer P. Russmessungen in der Aussenluft-Methodik und Reultate. Bern: Bundesamt fur Umwelt, Wld und Landschaft (BUWAL); 1997.

Most read articles by the same author(s)

1 2 3 > >>